AbbVie sours on $55B Shire deal after tax changes
Thursday, October 16, 2014 - 01:30
in Mathematics & Economics
AbbVie's board is recommending stockholders vote against its $55 billion takeover offer for drugmaker Shire after tax changes reduced the financial advantages of the deal.